Cantor Fitzgerald Maintains Overweight on Core Scientific, Lowers Price Target to $30

Benzinga · 1d ago
Cantor Fitzgerald analyst Brett Knoblauch maintains Core Scientific (NASDAQ:CORZ) with a Overweight and lowers the price target from $39 to $30.